With the Nifty Pharma index delivering a solid 14% return last year, the spotlight is on finding high-growth opportunities within the sector. This list highlights promising pharma penny stocks currently trading below ₹100, offering investors a chance to potentially capitalize on the pharmaceutical market
Sudarshan Pharma Industries Ltd
Incorporated in 2008, Sudarshan Pharma Industries Ltd manufactures API and Pharmaceutical Items. It also trades in Chemicals and Solvents. The Company operates both in domestic and international markets.
The company’s revenue from operations has surged by 3.01 percent from Rs.. 225 crores in H1FY24 to Rs. 232 crores in H1FY25. The net profits have grown by 20% from Rs. 5 crore in H1FY24 to Rs. 6 crore in H1FY25.
Market capitalization: Rs. 696.95 crores
Yearly stock returns: 293.21 percent
Current Share price: Rs.29.53
Shukra Pharmaceuticals Ltd
Incorporated in 1993, Shukra Pharmaceuticals Ltd manufactures and markets pharmaceutical products and does laboratory testing. The company has also assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceutical companies around the world
The company’s revenue from operations had increased by 90 percent from Rs 5.56 crores in Q2FY25 to Rs 10.58 crores in Q3FY25. The net profits had surged by 485.1 percent from Rs. 0.54 crore in Q2FY25 to Rs. 3.16 crore in Q3FY25.
Market capitalization: Rs. 898.53 crores
Yearly stock returns: 134.66 percent
Current Share price: Rs.. 19.5
Oxygenta Pharmaceutical Ltd
Oxygenta Pharmaceutical Ltd manufactures Bulk Drugs and API including Pharmaceutical preparation, and Organic Fine ChemicalsThe company manufactures a wide range of new-generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs. The company has its plant located at Medak in Andhra Pradesh.
The company’s revenue from operations had increased by 137 percent from Rs. 14.01 crores in Q2FY25 to Rs. 33.21 crores in Q3FY25.
Market capitalization: Rs. 285.03 crores
Yearly stock returns: 93.6 percent
Current Share price:Rs. 78.1
Zenith Drugs Ltd
Zenith Drugs Limited is a pharmaceutical company specializing in manufacturing and trading medicines, including generic drugs With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high-quality medicines to meet the needs of patients. The Company is mainly engaged in the business of manufacturing and Trading Medicine:
The company’s revenue from operations has reduced by 1.4 percent from Rs.69 crores in H1FY24 to Rs.68 crores in H1FY25. The net profits have stayed at Rs 6 crores during the same period.
Market capitalization: Rs. 146.37 crores
Yearly stock returns: 42.45 percent
Current Share price: Rs.89.6
Syncom Formulations (India) Ltd
Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products. The company is a generic pharmaceutical player operating in more than 15 countries worldwide, having more than 400 products registered
The company’s revenue from operations had increased by 25 percent from Rs 101 crores in Q2FY25 to Rs.127 crores in Q3FY25. The net profits had surged by 18 percent from Rs.11 crore in Q2FY25 to Rs.13 crore in Q3FY25.
Market capitalization: Rs. 1,633.72 crores
Yearly stock returns: 38.81 percent
Current Share price: Rs.17.56
Written by Likesh Babu S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any loss
